1,452
Views
0
CrossRef citations to date
0
Altmetric
Cardiovascular Medicine

Immune-mediated diseases and thromboembolic events: a modified Delphi panel

, , , , , , , , , & show all
Pages 1283-1291 | Received 14 Jan 2021, Accepted 17 May 2021, Published online: 14 Jun 2021

References

  • Hayter SM, Cook MC. Updated assessment of the prevalence, spectrum and case definition of autoimmune disease. Autoimmun Rev. 2012;11(10):754–765.
  • National Institutes of Health (NIH) Autoimmune Diseases Coordinating Committee. Progress in Autoimmune Diseases Research (Publication No. 05–5140). Washington (DC); 2005.
  • Wang L, Wang FS, Gershwin ME. Human autoimmune diseases: a comprehensive update. J Intern Med. 2015;278(4):369–395.
  • Thomas SL, Griffiths C, Smeeth L, et al. Burden of mortality associated with autoimmune diseases among females in the United Kingdom. Am J Public Health. 2010;100(11):2279–2287.
  • Rose NR. Prediction and prevention of autoimmune disease in the 21st century: a review and preview. Am J Epidemiol. 2016;183(5):403–406.
  • Roberts MH, Erdei E. Comparative United States autoimmune disease rates for 2010–2016 by sex, geographic region, and race. Autoimmun Rev. 2020;19(1):102423.
  • Schroeder KM, Gelwicks S, Naegeli AN, et al. Comparison of methods to estimate disease-related cost and healthcare resource utilization for autoimmune diseases in administrative claims databases. ClinicoEcon Outcomes Res. 2019;11:713–727.
  • Ogdie A, Kay McGill N, Shin DB, et al. Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general population-based cohort study. Eur Heart J. 2018;39(39):3608–3614.
  • Borjas-Howard JF, Leeuw K, Rutgers A, et al. Risk of recurrent venous thromboembolism in autoimmune diseases: a systematic review of the literature. Semin Thromb Hemost. 2019;45(2):141–149.
  • Zöller B, Li X, Sundquist J, et al. Autoimmune diseases and venous thromboembolism: a review of the literature. Am J Cardiovasc Dis. 2012;2(3):171–183.
  • Yuan M, Cao WF, Xie XF, et al. Relationship of atopic dermatitis with stroke and myocardial infarction: a meta-analysis. Medicine. 2018;97(49):e13512.
  • Schieir O, Tosevski C, Glazier RH, et al. Incident myocardial infarction associated with major types of arthritis in the general population: a systematic review and meta-analysis. Ann Rheum Dis. 2017;76(8):1396–1404.
  • Sun HH, Tian F. Inflammatory bowel disease and cardiovascular disease incidence and mortality: a meta-analysis. Eur J Prev Cardiol. 2018;25(15):1623–1631.
  • Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics – 2019 update: a report from the American Heart Association. Circulation. 2019;139(10):e56–e528.
  • Grosse SD, Nelson RE, Nyarko KA, et al. The economic burden of incident venous thromboembolism in the United States: a review of estimated attributable healthcare costs. Thromb Res. 2016;137:3–10.
  • Gregson J, Kaptoge S, Bolton T, et al. Cardiovascular risk factors associated with venous thromboembolism. JAMA Cardiol. 2019;4(2):163–173.
  • Nagy G, Németh N, Buzás EI. Mechanisms of vascular comorbidity in autoimmune diseases. Curr Opin Rheumatol. 2018;30(2):197–206.
  • Verden A, Dimbil M, Kyle R, et al. Analysis of spontaneous postmarket case reports submitted to the FDA regarding thromboembolic adverse events and JAK inhibitors. Drug Saf. 2018;41(4):357–361.
  • Yousuf MI. Using experts’ opinions through Delphi technique. Pract Assess Res Eval. 2007;12(4):1–8.
  • Hsu C-C, Sandford BA. The Delphi technique: making sense of consensus. Pract Assess Res Eval. 2007;12(10):1–8.
  • Caporali R, Carletto A, Conti F, et al. Using a modified Delphi process to establish clinical consensus for the diagnosis, risk assessment and abatacept treatment in patients with aggressive rheumatoid arthritis. Clin Exp Rheumatol. 2017;35(5):772–776.
  • Eubank BH, Mohtadi NG, Lafave MR, et al. Using the modified Delphi method to establish clinical consensus for the diagnosis and treatment of patients with rotator cuff pathology. BMC Med Res Method. 2016;16(1):56.
  • World Health Organization. WHO handbook for guideline development. Geneva: World Health Organization; 2014.
  • Dean SM, Abraham W. Venous thromboembolic disease in congestive heart failure. Congest Heart Fail. 2010;16(4):164–169.
  • Sejrup JK, Børvik T, Grimnes G, et al. Myocardial infarction as a transient risk factor for incident venous thromboembolism: results from a population-based case-crossover study. Thromb Haemost. 2019;119(8):1358–1364.
  • Murphy MK, Black NA, Lamping DL, et al. Consensus development methods, and their use in clinical guideline development. Health Technol Assess. 1998;2:i–iv,1–88.
  • Okoli C, Pawlowski S. The Delphi method as a research tool: an example, design considerations and applications. Inform Manage. 2004;42(1):15–29.
  • Hasson F, Keeney S, McKenna H. Research guidelines for the Delphi survey technique. J Adv Nurs. 2000;32(4):1008–1015.